Sculptor Capital’s Filana Therapeutics FLNA Stock Holding History

Sculptor Capital’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,300	Closed	-$1.13M	–	406
2023 Q4	$1.13M	Sell	50,300 -185,800	-79%	-$3.93M	0.02%	184
2023 Q3	$3.93M	Buy	+236,100	New	+$4.68M	0.08%	111
2023 Q1	–	Sell	-71,500	Closed	-$2.11M	–	627
2022 Q4	$2.11M	Sell	71,500 -5,000	-7%	-$180K	0.04%	349
2022 Q3	$3.2M	Hold	76,500	–	–	0.04%	441
2022 Q2	$2.15M	Buy	76,500 +18,900	+33%	+$477K	0.02%	538
2022 Q1	$2.14M	Sell	57,600 -148,900	-72%	-$6.31M	0.02%	596
2021 Q4	$9.02M	Sell	206,500 -29,700	-13%	-$1.56M	0.08%	217
2021 Q3	$14.7M	Buy	+236,200	New	+$19.7M	0.12%	119
2021 Q1	–	Sell	-30,300	Closed	-$207K	–	778
2020 Q4	$207K	Hold	30,300	–	–	﹤0.01%	453
2020 Q3	$349K	Buy	+30,300	New	+$137K	﹤0.01%	294

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sculptor Capital's FLNA Position: Q2 2024 in Review

Sculptor Capital sold out of Filana Therapeutics (FLNA) in Q2 2024, closing a stake of 32,270 shares — an estimated $655K sold.

Sculptor Capital first reported a position in FLNA in Q3 2020 and held it in 10 quarters. The position peaked at $14.7M in Q3 2021. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.

Sculptor Capital reported no remaining Filana Therapeutics position as of Q2 2024 after selling out during the quarter.
Sculptor Capital sold 32,270 Filana Therapeutics shares in Q2 2024, an estimated $655K.
Sculptor Capital first reported a position in Filana Therapeutics in Q3 2020 and held it in 10 quarters.
Sculptor Capital's Filana Therapeutics position peaked at $14.7M in Q3 2021.
145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.

Based on Sculptor Capital's 13F filing for Q2 2024, filed 14 Aug 2024.